Issued Patents All Time
Showing 1–12 of 12 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12391672 | Solid forms comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same | Lianfeng Huang, Udaykumar Jain, Hon-Wah Man, Paula A. Tavares-Greco, Wenju Wu | 2025-08-19 |
| 11566004 | Process for the preparation of bromodomain inhibitor | John F. Traverse, Kelvin Hin-Yeong Yong, Hekla Alite, Jonathan Moseley, Antonio Maria Ruda +2 more | 2023-01-31 |
| 11401257 | Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses | Paul F. Fernandez, Ying Li, Weihong Zhang | 2022-08-02 |
| 11370777 | Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same | Gerald D. Artman, III, Lianfeng Huang, Udaykumar Jain, Hon-Wah Man, Paula A. Tavares-Greco +3 more | 2022-06-28 |
| 10604510 | Solid forms comprising (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[B]azepine-4-carboxami compositions thereof, and uses thereof | Hon-Wah Man, Timothy D. Fitzpatrick, Anthony Joseph Frank, Ying Li, Xiaoling Lu +1 more | 2020-03-31 |
| 10517873 | Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use | Marie Georges Beauchamps, Robert Hilgraf, Mohit Atul Kothare, Hon-Wah Man, Mark A. Nagy +2 more | 2019-12-31 |
| 10202364 | Forms and compositions of an ERK inhibitor | Lianfeng Huang, Ying Li, John Traverse, Jean Xu, Kelvin Hin-Yeong Yong +1 more | 2019-02-12 |
| 10189808 | Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses | Paul F. Fernandez, Mohit Atul Kothare, Ying Li, Hon-Wah Man, Weihong Zhang | 2019-01-29 |
| 10005760 | Forms and compositions of an ERK inhibitor | Lianfeng Huang, Ying Li, John Traverse, Jean Xu, Kelvin Hin-Yeong Yong +1 more | 2018-06-26 |
| 9974786 | Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3- B]pyrazin-2(1H)-one, a solid form there of and methods of their use | Marie Georges Beauchamps, Juan Antonio Gamboa, Kevin J. Klopfer, William Edward Konnecke, Matthew Michael Kreilein +3 more | 2018-05-22 |
| 9795603 | Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use | Marie Georges Beauchamps, Juan Antonio Gamboa, Kevin J. Klopfer, William Edward Konnecke, Matthew Michael Kreilein +3 more | 2017-10-24 |
| 9604939 | Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use | Marie Georges Beauchamps, Juan Antonio Gamboa, Kevin J. Klopfer, William Edward Konnecke, Matthew Michael Kreilein +3 more | 2017-03-28 |